Hauptseite > Publikationsdatenbank > On the consensus nomenclature rules for radiopharmaceutical chemistry – Reconsideration of radiochemical conversion > print

001     893304
005     20220210164003.0
024 7 _ |a 10.1016/j.nucmedbio.2020.11.003
|2 doi
024 7 _ |a 0969-8051
|2 ISSN
024 7 _ |a 1872-9614
|2 ISSN
024 7 _ |a 2128/30583
|2 Handle
024 7 _ |a altmetric:95235160
|2 altmetric
024 7 _ |a pmid:33232876
|2 pmid
024 7 _ |a WOS:000620245100003
|2 WOS
037 _ _ |a FZJ-2021-02678
082 _ _ |a 570
100 1 _ |a Herth, Matthias M.
|0 P:(DE-HGF)0
|b 0
|e Corresponding author
245 _ _ |a On the consensus nomenclature rules for radiopharmaceutical chemistry – Reconsideration of radiochemical conversion
260 _ _ |a Amsterdam [u.a.]
|c 2021
|b Elsevier Science
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1643205827_9153
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Radiochemical conversion is an important term to be included in the “Consensus nomenclature rules for radiopharmaceuticalchemistry”. Radiochemical conversion should be used to define reaction efficiency by measuringthe transformation of components in a crude reactionmixture at a given time,whereas radiochemical yield is bettersuited to define the efficiency of an entire reaction process including, for example, separation, isolation, filtration,and formulation.
536 _ _ |a 5253 - Neuroimaging (POF4-525)
|0 G:(DE-HGF)POF4-5253
|c POF4-525
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de
700 1 _ |a Ametamey, Simon
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Antuganov, Dmitrii
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Bauman, Andreas
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Berndt, Mathias
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Brooks, Allen F.
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Bormans, Guy
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Choe, Yearn Seong
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Gillings, Nic
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Häfeli, Urs O.
|0 P:(DE-HGF)0
|b 9
700 1 _ |a James, Michelle L.
|0 P:(DE-HGF)0
|b 10
700 1 _ |a Kopka, Klaus
|0 P:(DE-HGF)0
|b 11
700 1 _ |a Kramer, Vasko
|0 P:(DE-HGF)0
|b 12
700 1 _ |a Krasikova, Raisa
|0 P:(DE-HGF)0
|b 13
700 1 _ |a Madsen, Jacob
|0 P:(DE-HGF)0
|b 14
700 1 _ |a Mu, Linjing
|0 P:(DE-HGF)0
|b 15
700 1 _ |a Neumaier, Bernd
|0 P:(DE-Juel1)166419
|b 16
700 1 _ |a Piel, Markus
|0 P:(DE-HGF)0
|b 17
700 1 _ |a Rösch, Frank
|0 P:(DE-HGF)0
|b 18
700 1 _ |a Ross, Tobias
|0 P:(DE-HGF)0
|b 19
700 1 _ |a Schibli, Roger
|0 P:(DE-HGF)0
|b 20
700 1 _ |a Scott, Peter J. H.
|0 P:(DE-HGF)0
|b 21
700 1 _ |a Shalgunov, Vladimir
|0 P:(DE-HGF)0
|b 22
700 1 _ |a Vasdev, Neil
|0 P:(DE-HGF)0
|b 23
700 1 _ |a Wadsak, Wolfgang
|0 P:(DE-HGF)0
|b 24
700 1 _ |a Zeglis, Brian M.
|0 P:(DE-HGF)0
|b 25
773 _ _ |a 10.1016/j.nucmedbio.2020.11.003
|g Vol. 93, p. 19 - 21
|0 PERI:(DE-600)1498538-X
|p 19 - 21
|t Nuclear medicine and biology
|v 93
|y 2021
|x 0969-8051
856 4 _ |y Restricted
|u https://juser.fz-juelich.de/record/893304/files/1-s2.0-S0969805120302882-main.pdf
856 4 _ |y Published on 2020-11-18. Available in OpenAccess from 2021-11-18.
|u https://juser.fz-juelich.de/record/893304/files/Autorenversion.docx
909 C O |o oai:juser.fz-juelich.de:893304
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 16
|6 P:(DE-Juel1)166419
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-525
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Decoding Brain Organization and Dysfunction
|9 G:(DE-HGF)POF4-5253
|x 0
913 0 _ |a DE-HGF
|b Key Technologies
|l Decoding the Human Brain
|1 G:(DE-HGF)POF3-570
|0 G:(DE-HGF)POF3-573
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-500
|4 G:(DE-HGF)POF
|v Neuroimaging
|x 0
914 1 _ |y 2021
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2021-01-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2021-01-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2021-01-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-01-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2021-01-30
915 _ _ |a Embargoed OpenAccess
|0 StatID:(DE-HGF)0530
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NUCL MED BIOL : 2019
|d 2021-01-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2021-01-30
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-01-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2021-01-30
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2021-01-30
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2021-01-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-01-30
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2021-01-30
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2021-01-30
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-5-20090406
|k INM-5
|l Nuklearchemie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)INM-5-20090406
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21